Sease, Ministry of Wellness of China, Beijing, P. R. China. 4Department of Nephrology, Peking University People’s Hospital, Beijing, P. R. China. 5Jilin University Fourth Hospital, Changchun, Jilin, P. R. China. 6Beijing Daxing district People’s Hospital, Beijing, P. R. China. 7 Guangwai Hospital, Beijing, P. R. China. 8Beijing No. 2 Hospital, Beijing, P. R. China. Received: ten November 2012 Accepted: 5 November 2013 Published: 14 November 2013 References 1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal illness. Am J Kidney Dis 1998, 32(five Suppl 3):S112 119.Zhang et al. BMC Nephrology 2013, 14:252 http://biomedcentral/1471-2369/14/Page 7 of2.three. four. 5.6.7.eight.9.ten. 11.12.13.14.15.16.17. 18.19.20.21.22.23. 24.Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascular COX-3 Inhibitor Biological Activity mortality in hemodialysis sufferers. Am J Kidney Dis 2000, 35(3):46976. Zoccali C: Cardiovascular threat in uraemic patients-is it totally explained by classical danger things Nephrol Dial Transplant 2000, 15(four):45457. Owen WF, Lowrie EG: C-reactive protein as an outcome predictor for upkeep hemodialysis individuals. Kidney Int 1998, 54(two):62736. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the threat of cardiovascular illness in apparently healthier men. N Engl J Med 1997, 336(14):97379. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: H3 Receptor Antagonist Purity & Documentation inflammation enhances cardiovascular risk and mortality in hemodialysis individuals. Kidney Int 1999, 55(two):64858. Morena M, Cristol JP, Bosc JY, Tetta C, Forret G, Leger CL, Delcourt C, Papoz L, Descomps B, Canaud B: Convective and diffusive losses of vitamin C throughout haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis individuals. Nephrol Dial Transplant 2002, 17(three):42227. Wang S, Eide TC, Sogn EM, Berg KJ, Sund RB: Plasma ascorbic acid in patients undergoing chronic haemodialysis. Eur J Clin Pharmacol 1999, 55(7):52732. Washio K, Inagaki M, Tsuji M, Morio Y, Akiyama S, Gotoh H, Gotoh T, Gotoh Y, Oguchi K: Oral vitamin C supplementation in hemodialysis individuals and its effect on the plasma amount of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative pressure marker. Nephron Clin Pract 2008, 109(2):c49 54. Sullivan JF, Eisenstein AB: Ascorbic acid depletion throughout hemodialysis. JAMA 1972, 220(13):1697699. Paniagua R, Frias Y, de Ventura MJ, Rodriguez E, Hurtado ME, Alcantara G, Vazquez R, Ortiz R, Salcedo M, Rios ME, et al: C-reactive protein and anti-Chlamydia pneumoniae antibodies as threat aspects of cardiovascular death in incident individuals on peritoneal dialysis. Perit Dial Int 2003, 23(two):13237. Zhang K, Liu L, Cheng X, Dong J, Geng Q, Zuo L: Low levels of vitamin C in dialysis individuals is linked with decreased prealbumin and increased C-reactive protein. BMC Nephrol 2011, 12:18. Fumeron C, Nguyen-Khoa T, Saltiel C, Kebede M, Buisson C, Drueke TB, Lacour B, Massy ZA: Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 2005, 20(9):1874879. Kamgar M, Zaldivar F, Vaziri ND, Pahl MV: Antioxidant therapy does not ameliorate oxidative pressure and inflammation in sufferers with end-stage renal illness. J Natl Med Assoc 2009, 101(four):33644. Kasai H: Evaluation of a kind of oxidative DNA damage, 8-hydroxy-2deoxyguanosine, as a marker of cellular oxidative stress throughout carcinogenesis. Mutat Res.
